BiotechTube

High dose ANAVEX2-73 + Mid dose ANAVEX2-73 + Placebo oral capsule

Phase 2/3Completed
0 watching 0 views this week⚡ Active
57
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Alzheimer Disease

Conditions

Alzheimer Disease

Trial Timeline

Jul 3, 2018 → Jun 30, 2022

NCT ID
NCT03790709

About High dose ANAVEX2-73 + Mid dose ANAVEX2-73 + Placebo oral capsule

High dose ANAVEX2-73 + Mid dose ANAVEX2-73 + Placebo oral capsule is a phase 2/3 stage product being developed by Anavex Life Sciences for Alzheimer Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT03790709. Target conditions include Alzheimer Disease.

Hype Score Breakdown

Clinical
22
Activity
15
Company
2
Novelty
7
Community
8

Clinical Trials (2)

NCT IDPhaseStatus
NCT03774459Phase 2Completed
NCT03790709Phase 2/3Completed

Competing Products

20 competing products in Alzheimer Disease

See all competitors
ProductCompanyStageHype Score
[18F]NAV4694Navidea BiopharmaceuticalsPhase 2
44
Bromocriptine Mesilate + PlacebosTowa PharmaceuticalPhase 1/2
40
LY450139 + PlaceboEli LillyPhase 3
77
Solanezumab + PlaceboEli LillyPhase 3
77
LY450139 dihydrate + placeboEli LillyPhase 2
52
Zagotenemab + PlaceboEli LillyPhase 2
52
Donanemab + Placebo + LY3202626Eli LillyPhase 2
52
Donanemab + PlaceboEli LillyPhase 3
77
GSK4527226AlectorPhase 2
44
AL002 + PlaceboAlectorPhase 2
44
GSK4527226AlectorPhase 2
44
AL002AlectorPhase 2
44
Solanezumab + PlaceboEli LillyPhase 3
77
donanemabEli LillyPhase 2
52
ATH-1017LeonaBioPhase 2/3
57
ATH-1017 + PlaceboLeonaBioPhase 2/3
57
ATH-1017 + PlaceboLeonaBioPhase 2
44
NDX-1017 + PlaceboLeonaBioPhase 1
25
simufilamCassava SciencesPhase 2
44
50 mg PTI-125 + 100 mg PTI-125 + 200 mg PTI-125Cassava SciencesPhase 1
25

Other Products from Anavex Life Sciences

ANAVEX2-73 + PlaceboPhase 3
69
ANAVEX2-73 oral liquid + Placebo oral liquidPhase 2/3
57
ANAVEX2-73Phase 2/3
57
ANAVEX3-71 oral capsules + Placebo oral capsulesPhase 2
44
High dose ANAVEX2-73 + Mid dose ANAVEX2-73 + Placebo oral capsulePhase 2
44